Population Pharmacokinetics of Intramuscular and Intravenous Ketamine in Children
Christoph P. Hornik(Duke University), Jan Hau Lee(St. Jude Children's Research Hospital), Michael Cohen‐Wolkowiez(Duke University), Barrie Harper(Clinical Research Institute), John van den Anker(Children's National), Andrew Lewandowski(Emmes (United States)), Chiara Melloni, Daniel González(University of North Carolina at Chapel Hill), Andrew M. Atz(Medical University of South Carolina), Casey E. Gelber(Emmes (United States)), Ram Yogev(Northwestern University), Kee Chong Ng(KK Women's and Children's Hospital), Brenda B. Poindexter(Cincinnati Children's Hospital Medical Center)
Cited by 21
Related Papers
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach
|American Journal of Respiratory and Critical Care Medicine|2019|1.2k
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828